| Literature DB >> 31998066 |
Tomoyuki Segawa1, Thomas Baudry1, Alexis Bourla1,2, Jean-Victor Blanc1, Charles-Siegfried Peretti1, Stephane Mouchabac1, Florian Ferreri1.
Abstract
Background: Substance Use Disorder (SUD) and behavioral addictions are common and require a multidisciplinary approach. New technologies like Virtual Reality could have the potential to improve assessment and treatment of these disorders. Objective: In the present paper, we therefore present an overview of Virtual Reality (Head Mounted Devices) in the field of addiction medicine for craving assessment and treatment. Method: We conducted a systematic review by querying PubMed database for the titles of articles published up to March 2019 with the terms [virtual] AND [addictive] OR [addiction] OR [substance] OR [alcohol] OR [cocaine] OR [cannabis] OR [opioid] OR [tobacco] OR [nicotine] OR [methamphetamine] OR [gaming] OR [gambling].Entities:
Keywords: addictive behavior; alcohol; cocain; nicotine; virtual reality
Year: 2020 PMID: 31998066 PMCID: PMC6965009 DOI: 10.3389/fnins.2019.01409
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Figure 1PRISMA flow diagram.
Summary of concepts underlying Virtual Reality and type of cue.
| Virtual reality | An advanced human-computer interface that simulates a realistic environment and allows participants to interact with it. Its purpose is to allow a person sensory-motor and cognitive activity in an artificial world, created numerically, which can be imaginary, symbolic or a simulation of certain aspects of the real world. Each VR application is characterized by two key criteria: presence and autonomy. | Ouramdane et al., |
| Virtual environment | The place suggested by the VR, represented by a 3D model of real or imaginary data that can be visualized and with which participants can interact in real time. | Ouramdane et al., |
| Immersion | The objective description of what a VR display can provide in terms of technologies. It includes the extent to which the display is extensive (number of sensory systems involved), surrounding (information can arrive from any direction), inclusive (all information from the real world is shut out), vivid (richness and quality of the sensory information generated) and matching (a match is needed between information generated and participant's proprioceptive feedback). It also requires a self-presentation in the virtual environment i.e., a virtual body. | Slater et al., |
| Presence | The subjective, psychological feeling of “being there”, in the place depicted by the virtual environment. Immersion, control over environments, naturalness and realness of interactions all together contribute to the sense of presence. | Witmer and Singer, |
| Head-Mounted Display (HMD) | The most immersive device: it displays separated images for each eye allowing stereo vision with stereo earphones and head tracking continually capturing the position and orientation of the participant's head. Rather than being a passive, external observer of video images, it allows participants to see a surrounding 3D stereo scene that can change dynamically. | Anderson et al., |
| Cybersickness | A constellation of motion sickness-like symptoms occurring during and upon VR exposure. It includes symptoms such as disorientation, dizziness and nausea. and may be considered as a potential threat to the ultimate usability of virtual reality. | Stanney et al., |
| Craving | Defined by the subjective preoccupation or strong desire to use a drug, craving has become a major diagnostic criterion of addictive disorders and is considered a central feature of addiction. | Sayette, |
| Psycho-physiological response | These responses, controlled by the autonomic nervous system, are considered objective markers of cue-reactivity. Heart rate, skin conductance and temperature are the most studied psychological responses. | Conklin and Tiffany, |
| Attention to cue | Referring to attention bias, attention to cue is the motivational trend to focus on drug cues while neglecting or ignoring others type of stimuli. | Field et al., |
| Proximal cues | This is the most frequent type of cue used in traditional cue-reactivity studies. Proximal cues are ubiquitous across drug use. They are more often visual cues such as cigarette, ashtray, lighters, bottle of alcohol but can also be olfactory, auditory and tactile. | Conklin et al., |
| Contextual (or distal) cues | They refer to the environment or context, with or without social interaction, in which substance use occurs such as bar or party. As well as proximal cues and despite being less reliable, they can elicit conditioned responses by being previously paired with drug use. | Conklin et al., |
| Complex cues | A combination of proximal and contextual cues. They represent a more complete picture of real-world stimuli (people drinking alcohol in a party or smokers gathering outside a bar). | Conklin et al., |
Clinical trial on Virtual Reality (VR) assessment of craving in addiction.
| Lee et al. ( | −22 TS, moderate ND | - C: complex/CC: smoking-related pictures | - VAS | - ↑ Craving |
| Lee et al. ( | −8 TS, moderate ND | - C: complex/CC: smoking-related pictures or VR neutral | - VAS | - ↑ CravingActivation of PFC |
| Bordnick et al. ( | −13 NTS, ND | - C: proximal or complex cues/CC: VR neutral | - VAS | - ↑ Craving |
| Bordnick et al. ( | −10 NTS, ND | - VAS | - ↑ Craving and SCR | |
| Carter et al. ( | −22 NTS, ND | - C: complex/CC: VR neutral | - MDS, brief QSU items | - ↑ Craving |
| Traylor et al. ( | −20 NTS, moderate ND | - C: proximal or complex cues/CC: VR neutral | - VAS, | - ↑ Craving |
| Traylor et al. ( | −20 NTS, moderate ND | - C: proximal or complex/CC: VR neutral | - ACVAS, SoSQ | - ↑ Attention to cues |
| Ferrer-García et al. ( | −25 NTS, smokers (>10 cig/d) | - C: 7 complex/CC: VR neutral | - VAS, cig/day | - ↑ Craving |
| Traylor et al. ( | −14 NTS, moderate ND | - C: 2 complex/CC: VR neutral | - VAS | - ↑ Craving |
| Pericot-Valverde et al. ( | −46 NTS, ND | - C: 2 complex (+/– social pressure) | - VAS | - ↑ Craving |
| Kaganoff et al. ( | −46 TS (NRT +/– CBT), ND | - C: proximal or complex/CC: VR neutral | - Intake, week 4 and week 10 of treatment: VAS, SAS | - ↑ Craving |
| Paris et al. ( | −24 NTS, smokers (>10 cig/day) | - C: complex or contextual/CC: 2 VR neutral | - VAS | - ↑ Craving |
| García-Rodríguez et al. ( | −46 NTS, smokers (>10 cig/day) | - C: 7 complex/CC: VR neutral | - VAS | - ↑ Craving in smoker group. |
| García-Rodríguez et al. ( | −45 NTS, smokers (>10 cig/day) | - C: Smoking a virtual cigarette in complex environment/CC: virtual darts in complex environment or complex environment alone | - VAS | - ↑ Craving |
| Acker and MacKillop ( | −47 NTS, low to moderate ND1 (>10 cig/day) | - C: proximal/CC: VR neutral | - VAS | - ↑ Craving |
| Gamito et al. ( | −21 NTS, low ND | - C: complex / CC: contextual | - QSU-Brief | - ↑ In smoker group in complex environment |
| Thompson-Lake et al. ( | −36 NTS, high ND | - C: proximal or complex. CC: VR neutral—Randomized, 3 min exposure | - QSU-Brief, FTND, Withdrawal Scale (12 h Deprived) | - ↑ Craving |
| Lee et al. ( | −14 TS (abstinent 3 weeks), substantial AD | - C: complex +/– social pressure. CC: VR neutral +/– social pressure | - VAS | - ↑ Craving in alcoholic group vs. social drinkers in complex environment |
| Bordnick et al. ( | −40 NTS, AD | - C: 4 complex (2 with social pressure) / CC: VR neutral | - VAS | - ↑ Craving |
| Ryan et al. ( | −15 NTS, binge drinkers | - C: 4 complex (2 with social pressure) / CC: VR neutral | - VAS | - ↑ Craving in binge vs. non-binge drinkers in two complex environments (1 with social pressure) |
| Traylor et al. ( | −14 NTS, moderate ND | - C: 2 complex smoking cues / CC: VR neutral | - VAS | - ↑ OH craving in OH group vs. non-OH group in one complex environment |
| Kim and Lee ( | −18, HSD | - C: 4 complex / CC: 4 VR neutral | - VAAT (Duration of push or pull response) | - ↑ Attention to cue in HSD |
| Saladin et al. ( | −11 NTS, CoD | - C: 7 contextual or complex /CC: VR neutral | - VAS | - ↑ Craving |
| Bordnick et al. ( | −20 NTS, CaD | - C: 1 proximal and 1 complex / CC: VR neutral | - VAS | - ↑ Craving |
| Bouchard et al. ( | −28 NTS, frequent gamblers | - C: 2 complex / CC: real VLT and real board game | - GCS | - ↑ Craving (anticipation and desire scores) vs. real board game in frequent gamblers group |
| Shin et al. ( | -−34 NTS, IGD | - C: 4 complex | - VAS | - ↑ Craving in IGD group vs. control group |
FTND.
DSM-IV.
ADS (Alcohol dependence scale).
DSM-IV-TR.
AUDIT > 8.
AUDIT < 8.
SOGS.
DSM-V.
occasional or frequent problems because of internet at IAT.
AAS, Alcohol Attention Scale; ACVAS, Attention to Cue Visual Analog Scale; AD, Alcohol dependent; AUDIT, Alcohol Use Disorder Identification Test; BDI, Beck Depression Inventory; C, Cue; CaD, Cannabis dependent; CAS, Cannabis, Attention Scale; CC, Control Cue; CoD, Cocaine dependent; CT, Controlled Trial; fMRI, functional Magnetic Resonance Imaging; FTND, Fagerström Test for Nicotine Dependence; GCS, Gambling Craving Scale; HR, Heart Rate; HSD, Heavy, Social Drinkers; IAT, Young Internet Addiction Test; IG, Internet Gaming; LSD, Light Social Drinkers; MDS, Multi-Dimensional Scale; ND, Nicotine dependent; NTS, Non Treatment Seeking; OH, alcohol; PFC, Pre-Frontal Cortex; PQ, Presence Questionnaire; QSU, Questionnaire of Smoking Urge; RCT, Randomized Controlled Trial; SAS, Smoking Attention Scale; SCR, Skin Conductance Response; SOGS, South Oak Gambling Scale; SoSQ, attitude toward Sense of Smell Questionnaire; SR, Skin Resistance; T, Temperature; TS, Treatment Seeking; VAAT, Virtual Approach Avoidance Task; VAS, Visual Analog Scale; VLT, Video Lottery Terminal; VR, Virtual Reality.
Clinical trial on Virtual Reality (VR) treatment in addiction.
| Lee et al. ( | - Trial | −15 adolescent males, low to moderate ND1 | - VET (20 min, 1 session) 20 min sessions | N | - Baseline, end of treatment: VAS, morning and daily smoking count, planning (min), FTND, SSQ, PQ | - No change in craving and others variables | |
| Pericot-Valverde et al. ( | - Trial | −48 TS, low to moderate ND | - VET: progressive individualized exposure (30 min, 5 sessions, 1/w) | Y | - Baseline, end of treatment: VAS, cig/d, air expired CO | - ↓ Craving | |
| Pericot-Valverde et al. ( | - Trial | −41 TS, low to moderate ND | - VET: degressive individualized exposure (30 min, 5 sessions, 1/w) | N | - Baseline: gender, age, years of education, marital status, duration of daily smoking, FTND, NDSS, MNWS, STAI, BDI-II, DD | - ↓ Craving; correlated with younger age, higher Cig/day, DD, BDI-II | |
| Park et al. ( | - CT | −30 TS males, moderate ND | - TTT: CBT (4 sessions, 1/w) | - VET: 2 complex and 2 neutral (25 min, 4 sessions, 1/w) | N | - Baseline, end of treatment, week 12: QSU, cig/d, air expired CO, FTND, MNWS (per protocole analysis) | - No change in craving- No difference on craving |
| Pericot-Valverde et al. ( | - RCT | −102 TS, moderate ND | - TTT: CBT (60 min, 6 sessions, 1/w) | - VET (+CBT): progressive individualized exposure (30 min, 5 sessions, 1/w) | N | - Baseline and month 1, 6, 12: VAS, abstinence, relapse rate, treatment retention (ITT analysis) | - ↓ Craving |
| Girard et al. ( | - RCT | −91 outpatients, moderate to high ND | - TTT: Grasp up to 60 virtual balls (30 min, 4 sessions, 1/w) | - VBT: find and crush up to 60 virtual cigarettes (30 min, 4 sessions, 1/w) | N | - Baseline, end of treatment, week 12: cig/d, air expired CO, FTND, PQ, SSQ (ITT analysis) | - ↓ Dependence |
| Bordnick et al. ( | - RCT | −46 TS, moderate to high ND | - TTT: NRT | - VCBT: progressive individualized exposure and coping skill training (1 h, 10 sessions, 1/w) | Y | - Baseline, end of treatment: QSU-Brief, cig/d, SASE | - ↓ Craving |
| Lee et al. ( | - CT | −38 inpatient males, AD | - TTT: CBT + education (45 min, 10 sessions, 2/w) | - VET: relaxation, exposure, aversive situation (25 min, 10 sessions, 2/w) | Y | - Baseline, end of treatment: VAS, EEG | - ↓ Craving |
| Son et al. ( | - Trial | −12 inpatient, AD | - Group: 15 healthy subjects | - VET: relaxation, exposure, aversive situation (25 min, 10 sessions, 2/w) | Y | - Baseline, end of treatment: VAS, TEP-FDG | - ↓ Craving |
| Choi and Lee ( | - Trial | −20 male, HSD | - Group: 20 male LD | - VET: 2 social aversive situations (20 min, 1 session) | N | - Baseline, end of treatment: AUQ, alcohol-IAT, eye-tracking test, alcohol-Stroop test. | - ↓ Craving |
| Giroux et al. ( | - Trial | −10 outpatient, gamblers | - VET: progressive exposure (20 min, 1 session) | Y | - Baseline, post treatment: VAS, self-efficacy | - No change in craving and self-efficacy | |
| Bouchard et al. ( | - CT | - Study 1: 28, frequent gamblers | - TTT: | - VET: 2 complex (7 min each, 1 session) | Y | - Baseline, post treatment: GCS, SOGS | - ↑ Craving in VR gambling and real VLT; correlated to baseline SOGS; correlated to baseline SOGS |
| - Study 2: 34 inpatient, pathological gamblers | - TTT: imaginal exposure (2 sessions) | - VET: 2 complex (20 min, 2 session) | Y | - Baseline, post treatment: GCS, SSQ | - ↓ Craving | ||
| - Study 3: 25, pathological gamblers | - TTT: imaginal exposure (4 sessions) | - VET: 2 complex scenes (20 min, 4 session) | Y | - Baseline, post treatment: My treatment, questionnaire, effectiveness (CPGI, DIG, GRCS) | - ↓ Craving | ||
| Park et al. ( | - RCT | −24, IGD | - TTT: CBT (2 h, 8 sessions, 2/w) | - VET: relaxation, exposure, aversive situation (2 h, 8 sessions, 2/w) | Y | - Baseline, post treatment: YIAS, fMRI | - ↓ YIAS in both conditions |
FTND.
DSM-IV-TR.
DSM-V.
DSM-IV.
AUDIT >8.
AUDIT <8.
SOGS.
IYAS>50.
A, Assisted by a therapist; AUDIT, Alcohol Use Disorder Identification Test; AUQ, Alcohol Urge Questionnaire; CBT, Cognitive-Behavioral Therapy; CO, Carbone monOxyde; CPGI, Canadian Problem Gambling Index; CT, Controlled Trial; DD, Delay Discounting; DIG, Diagnostic Interview for Gambling; EEG, Electroencephalography; FDG-PET, Fluoro-Deoxy-Glucose Positron Emission Tomography; FTND, Fagerström Test for Nicotine Dependence; GCS, Gambling Craving Scale; GRCS, Gambling Related Cognition Scale; HSD, Heavy social drinkers, IAT, Implicit Association Test; ITT, Intention To Treat; LD, Light Drinkers; MNWS, Minnesota Nicotine Withdrawal Scale; NDSS, Nicotine Dependence Syndrome Scale; NTS, Non-Treatment Seeking; PCC, Posterior Cingulate Cortex; PQ, Presence Questionnaire; QSU, Questionnaire of Smoking Urge; RCT, Randomized Controlled Trial; SASE, Smoking Abstinence self-efficacy; SCQ, Smoking Confidence Questionnaire; SSQ, Simulator Sickness Questionnaire; STAI, State-Trait Anxiety Inventory; TS, Treatment Seeking; VAS, Visual analog Scale; VBT, Virtual Behavioral Therapy; VCBT, Virtual cognitive-Behavioral Therapy; VET, Virtual Exposure Therapy; VLT, Video Lottery Terminal; YIAS, Young Internet Addiction Scale; YIAS, Young Internet Addiction Scale.
| Population | Adolescent or adult humans with SUD or behavioral addiction |
| Intervention | Immersive VR (using Head-Mounted Display) simulating drug-related cues for assessment or treatment |
| Comparators | - Assessment: virtual neutral stimuli por traditional exposition (photos, videos, imagination), |
| Outcomes | - Assessment: variation of cue reactivity (level of craving, physiological responses, attention to cue) |
| Study designs | Randomized controlled trial (RCT), controlled trial (CT), trial (T), case series |
| Timing | Studies running up to March 2019 |
| Language | English or French |